PACIRA BIOSCIENCES, INC. Research and Development Expense
PACIRA BIOSCIENCES, INC. (PCRX) reported Research and Development Expense of $30.24 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. research and development expense for the quarter ending 2026-06-30 was $30.24M, a 7.24% increase year-over-year.
- PACIRA BIOSCIENCES, INC. research and development expense for the quarter ending 2026-03-31 was $28.07M, a 10.77% increase year-over-year.
- PACIRA BIOSCIENCES, INC. research and development expense for the quarter ending 2025-12-31 was $37.45M, a 56.73% increase year-over-year.
- PACIRA BIOSCIENCES, INC. research and development expense for the quarter ending 2025-09-30 was $25.97M, a 35.92% increase year-over-year.
- PACIRA BIOSCIENCES, INC. research and development expense for fiscal 2025 was $117.31M, a 43.81% increase from fiscal 2024.
- PACIRA BIOSCIENCES, INC. research and development expense for fiscal 2024 was $81.58M, a 6.98% increase from fiscal 2023.
- PACIRA BIOSCIENCES, INC. research and development expense for fiscal 2023 was $76.26M, a 10.07% decline from fiscal 2022.
- PACIRA BIOSCIENCES, INC. research and development expense for fiscal 2022 was $84.80M, a 52.66% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $30.24M 10-Q · filed 2026-08-04 | $58.31M 10-Q · filed 2026-08-04 | $95.77M derived: sum of 3 quarters · filed 2026-08-04 | $121.73M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | $28.07M 10-Q · filed 2026-04-30 | $65.53M derived: sum of 2 quarters · filed 2026-04-30 | $91.49M derived: sum of 3 quarters · filed 2026-04-30 | $119.69M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | $37.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $63.42M derived: sum of 2 quarters · filed 2026-02-26 | $91.62M derived: sum of 3 quarters · filed 2026-08-04 | $117.31M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $25.97M 10-Q · filed 2025-11-06 | $54.17M derived: sum of 2 quarters · filed 2026-08-04 | $79.86M 10-Q · filed 2025-11-06 | $103.41M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | $28.20M 10-Q · filed 2026-08-04 | $53.89M 10-Q · filed 2026-08-04 | $77.44M derived: sum of 3 quarters · filed 2026-08-04 | $96.54M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | $25.34M 10-Q · filed 2026-04-30 | $49.24M derived: sum of 2 quarters · filed 2026-04-30 | $68.34M derived: sum of 3 quarters · filed 2026-04-30 | $88.68M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $23.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $43.00M derived: sum of 2 quarters · filed 2026-02-26 | $63.34M derived: sum of 3 quarters · filed 2026-02-26 | $81.58M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $19.10M 10-Q · filed 2025-11-06 | $39.44M derived: sum of 2 quarters · filed 2025-11-06 | $57.68M 10-Q · filed 2025-11-06 | $77.14M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $20.34M 10-Q · filed 2025-08-05 | $38.58M 10-Q · filed 2025-08-05 | $58.04M derived: sum of 3 quarters · filed 2026-02-26 | $78.87M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $18.24M 10-Q · filed 2025-05-08 | $37.70M derived: sum of 2 quarters · filed 2026-02-26 | $58.53M derived: sum of 3 quarters · filed 2026-02-26 | $77.36M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $19.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $40.29M derived: sum of 2 quarters · filed 2026-02-26 | $59.12M derived: sum of 3 quarters · filed 2026-02-26 | $76.26M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $20.83M 10-Q · filed 2024-11-06 | $39.65M derived: sum of 2 quarters · filed 2024-11-06 | $56.79M 10-Q · filed 2024-11-06 | $74.30M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $18.82M 10-Q · filed 2024-07-30 | $35.96M 10-Q · filed 2024-07-30 | $53.47M derived: sum of 3 quarters · filed 2025-02-27 | $72.87M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $17.14M 10-Q · filed 2024-05-07 | $34.65M derived: sum of 2 quarters · filed 2025-02-27 | $54.05M derived: sum of 3 quarters · filed 2025-02-27 | $80.33M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $17.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $36.91M derived: sum of 2 quarters · filed 2025-02-27 | $63.19M derived: sum of 3 quarters · filed 2025-02-27 | $84.80M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $19.41M 10-Q · filed 2023-11-02 | $45.69M derived: sum of 2 quarters · filed 2023-11-02 | $67.29M 10-Q · filed 2023-11-02 | $82.81M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $26.28M 10-Q · filed 2023-08-02 | $47.89M 10-Q · filed 2023-08-02 | $63.40M derived: sum of 3 quarters · filed 2024-02-29 | $74.98M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $21.61M 10-Q · filed 2023-05-03 | $37.12M derived: sum of 2 quarters · filed 2024-02-29 | $48.70M derived: sum of 3 quarters · filed 2024-02-29 | $61.27M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $15.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $27.09M derived: sum of 2 quarters · filed 2024-02-29 | $39.66M derived: sum of 3 quarters · filed 2024-02-29 | $55.55M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $11.58M 10-Q · filed 2022-11-03 | $24.15M derived: sum of 2 quarters · filed 2022-11-03 | $40.03M 10-Q · filed 2022-11-03 | $55.36M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $12.57M 10-Q · filed 2022-08-03 | $28.45M 10-Q · filed 2022-08-03 | $43.78M derived: sum of 3 quarters · filed 2023-02-28 | $58.43M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $15.88M 10-Q · filed 2022-05-04 | $31.21M derived: sum of 2 quarters · filed 2023-02-28 | $45.86M derived: sum of 3 quarters · filed 2023-02-28 | $59.48M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $15.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $29.98M derived: sum of 2 quarters · filed 2023-02-28 | $43.60M derived: sum of 3 quarters · filed 2023-02-28 | $59.42M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $14.65M 10-Q · filed 2021-11-03 | $28.27M derived: sum of 2 quarters · filed 2021-11-03 | $44.09M 10-Q · filed 2021-11-03 | $63.74M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $13.62M 10-Q · filed 2021-08-03 | $29.44M 10-Q · filed 2021-08-03 | $49.09M derived: sum of 3 quarters · filed 2022-02-28 | $69.35M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $15.82M 10-Q · filed 2021-05-04 | $35.47M derived: sum of 2 quarters · filed 2022-02-28 | $55.73M derived: sum of 3 quarters · filed 2022-02-28 | $73.55M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $19.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $39.91M derived: sum of 2 quarters · filed 2022-02-28 | $57.73M derived: sum of 3 quarters · filed 2022-02-28 | $72.12M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $20.25M 10-Q · filed 2020-10-30 | $38.08M derived: sum of 2 quarters · filed 2020-10-30 | $52.47M 10-Q · filed 2020-10-30 | $66.64M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | $17.83M 10-Q · filed 2020-08-06 | $32.21M 10-Q · filed 2020-08-06 | $46.38M derived: sum of 3 quarters · filed 2021-03-01 | $61.28M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | $14.38M 10-Q · filed 2020-05-07 | $28.56M derived: sum of 2 quarters · filed 2021-03-01 | $43.45M derived: sum of 3 quarters · filed 2021-03-01 | $55.69M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $14.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $29.07M derived: sum of 2 quarters · filed 2021-03-01 | $41.31M derived: sum of 3 quarters · filed 2021-03-01 | $55.69M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $14.90M 10-Q · filed 2019-11-08 | $27.14M derived: sum of 2 quarters · filed 2019-11-08 | $41.51M 10-Q · filed 2019-11-08 | $51.54M derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2018-06-30 | $12.24M 10-Q · filed 2019-08-08 | $26.62M 10-Q · filed 2019-08-08 | $36.65M derived: sum of 3 quarters · filed 2020-02-21 | $48.42M derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2018-03-31 | $14.38M 10-Q · filed 2019-05-02 | $24.41M derived: sum of 2 quarters · filed 2020-02-21 | $36.18M derived: sum of 3 quarters · filed 2020-02-21 | $55.04M derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2017-12-31 | $10.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $21.80M derived: sum of 2 quarters · filed 2020-02-21 | $40.66M derived: sum of 3 quarters · filed 2020-02-21 | $57.29M 10-K · filed 2020-02-21 | |||
| 2017-09-30 | $11.78M 10-Q · filed 2018-11-01 | $30.63M derived: sum of 2 quarters · filed 2018-11-01 | $47.26M 10-Q · filed 2018-11-01 | $64.33M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-06-30 | $18.86M 10-Q · filed 2018-08-02 | $35.49M 10-Q · filed 2018-08-02 | $52.56M derived: sum of 3 quarters · filed 2019-02-28 | $62.31M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $16.63M 10-Q · filed 2018-05-03 | $33.70M derived: sum of 2 quarters · filed 2019-02-28 | $43.45M derived: sum of 3 quarters · filed 2019-02-28 | $52.82M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | $17.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $26.82M derived: sum of 2 quarters · filed 2019-02-28 | $36.19M derived: sum of 3 quarters · filed 2019-02-28 | $45.68M 10-K · filed 2019-02-28 | |||
| 2016-09-30 | $9.75M 10-Q · filed 2017-11-08 | $19.12M derived: sum of 2 quarters · filed 2017-11-08 | $28.61M 10-Q · filed 2017-11-08 | $41.76M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | $9.36M 10-Q · filed 2017-08-02 | $18.86M 10-Q · filed 2017-08-02 | $32.01M derived: sum of 3 quarters · filed 2018-02-28 | $37.90M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-03-31 | $9.49M 10-Q · filed 2017-05-04 | $22.65M derived: sum of 2 quarters · filed 2018-02-28 | $28.54M derived: sum of 3 quarters · filed 2018-02-28 | $32.19M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-12-31 | $13.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $19.05M derived: sum of 2 quarters · filed 2018-02-28 | $22.70M derived: sum of 3 quarters · filed 2018-02-28 | $28.66M 10-K · filed 2018-02-28 | |||
| 2015-09-30 | $5.89M 10-Q · filed 2016-11-02 | $9.54M derived: sum of 2 quarters · filed 2016-11-02 | $15.51M 10-Q · filed 2016-11-02 | $34.24M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $3.65M 10-Q · filed 2016-08-04 | $9.62M 10-Q · filed 2016-08-04 | $28.35M derived: sum of 3 quarters · filed 2017-03-01 | $32.77M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $5.97M 10-Q · filed 2016-05-02 | $24.70M derived: sum of 2 quarters · filed 2017-03-01 | $29.12M derived: sum of 3 quarters · filed 2017-03-01 | $34.34M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $18.73M 10-K · filed 2017-03-01 | $23.16M derived: sum of 2 quarters · filed 2017-03-01 | $28.37M derived: sum of 3 quarters · filed 2017-03-01 | $18.73M 10-K · filed 2016-02-25 | |||
| 2014-09-30 | $4.42M 10-Q · filed 2015-10-27 | $9.64M derived: sum of 2 quarters · filed 2015-10-27 | $14.84M 10-Q · filed 2015-10-27 | $19.68M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-06-30 | $5.22M 10-Q · filed 2015-07-30 | $10.42M 10-Q · filed 2015-07-30 | $15.26M derived: sum of 3 quarters · filed 2016-02-25 | $21.22M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-03-31 | $5.20M 10-Q · filed 2015-04-30 | $10.04M derived: sum of 2 quarters · filed 2016-02-25 | $16.00M derived: sum of 3 quarters · filed 2016-02-25 | $20.86M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2013-12-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $10.80M derived: sum of 2 quarters · filed 2016-02-25 | $15.65M derived: sum of 3 quarters · filed 2016-02-25 | $21.56M 10-K · filed 2016-02-25 | |||
| 2013-09-30 | $5.96M 10-Q · filed 2014-10-30 | $10.82M derived: sum of 2 quarters · filed 2014-10-30 | $16.72M 10-Q · filed 2014-10-30 | $19.97M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-06-30 | $4.86M 10-Q · filed 2014-07-31 | $10.76M 10-Q · filed 2014-07-31 | $14.01M derived: sum of 3 quarters · filed 2015-02-24 | $17.53M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2013-03-31 | $5.91M 10-Q · filed 2014-05-01 | $9.15M derived: sum of 2 quarters · filed 2015-02-24 | $12.68M derived: sum of 3 quarters · filed 2015-02-24 | $14.55M derived: sum of 4 quarters · filed 2015-02-24 | |||
| 2012-12-31 | $3.24M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $6.77M derived: sum of 2 quarters · filed 2015-02-24 | $8.64M derived: sum of 3 quarters · filed 2015-02-24 | $9.94M 10-K · filed 2015-02-24 | |||
| 2012-09-30 | $3.53M 10-Q · filed 2013-10-31 | $5.40M derived: sum of 2 quarters · filed 2013-10-31 | $6.69M 10-Q · filed 2013-10-31 | $8.82M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-06-30 | $1.87M 10-Q · filed 2013-08-06 | $3.17M 10-Q · filed 2013-08-06 | $5.30M derived: sum of 3 quarters · filed 2014-02-25 | $9.66M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2012-03-31 | $1.29M 10-Q · filed 2013-05-08 | $3.42M derived: sum of 2 quarters · filed 2014-02-25 | $7.79M derived: sum of 3 quarters · filed 2014-02-25 | $12.37M derived: sum of 4 quarters · filed 2014-02-25 | |||
| 2011-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $6.49M derived: sum of 2 quarters · filed 2014-02-25 | $11.08M derived: sum of 3 quarters · filed 2014-02-25 | $14.87M 10-K · filed 2014-02-25 | |||
| 2011-09-30 | $4.36M 10-Q · filed 2012-11-01 | $4.34M 10-Q · filed 2011-10-31 | $8.95M derived: sum of 2 quarters · filed 2012-11-01 | $12.74M 10-Q · filed 2012-11-01 | $12.24M 10-Q · filed 2011-10-31 | $16.41M derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-06-30 | $4.59M 10-Q · filed 2012-08-09 | $4.38M 10-Q · filed 2011-08-11 | $8.38M 10-Q · filed 2012-08-09 | $7.89M 10-Q · filed 2011-08-11 | $12.05M derived: sum of 3 quarters · filed 2013-03-07 | $17.77M derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-03-31 | $3.79M 10-Q · filed 2012-05-09 | $7.47M derived: sum of 2 quarters · filed 2013-03-07 | $13.19M derived: sum of 3 quarters · filed 2013-03-07 | $17.78M derived: sum of 4 quarters · filed 2013-03-07 | |||
| 2010-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $9.39M derived: sum of 2 quarters · filed 2013-03-07 | $13.99M derived: sum of 3 quarters · filed 2013-03-07 | $18.63M 10-K · filed 2013-03-07 | |||
| 2010-09-30 | $5.72M 10-Q · filed 2011-10-31 | $10.31M derived: sum of 2 quarters · filed 2011-10-31 | $14.95M 10-Q · filed 2011-10-31 | ||||
| 2010-06-30 | $4.60M 10-Q · filed 2011-08-11 | $9.24M 10-Q · filed 2011-08-11 | |||||
| 2009-12-31 | $26.23M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |